These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 24837411)
1. Combination therapy in the treatment of experimental invasive fungal infection by Sarocladium (Acremonium) kiliense. Fernández-Silva F; Capilla J; Mayayo E; Sutton D; Guarro J Int J Antimicrob Agents; 2014 Aug; 44(2):136-9. PubMed ID: 24837411 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense. Fernández-Silva F; Capilla J; Mayayo E; Sutton DA; Hernández P; Guarro J Antimicrob Agents Chemother; 2013 Dec; 57(12):6265-9. PubMed ID: 24100490 [TBL] [Abstract][Full Text] [Related]
3. Sarocladium and Acremonium infections: New faces of an old opportunistic fungus. Pérez-Cantero A; Guarro J Mycoses; 2020 Nov; 63(11):1203-1214. PubMed ID: 33090564 [TBL] [Abstract][Full Text] [Related]
4. Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana. Mariné M; Pastor FJ; Guarro J Med Mycol; 2009 Feb; 47(1):45-9. PubMed ID: 19085457 [TBL] [Abstract][Full Text] [Related]
5. Combined therapy in treatment of murine infection by Fusarium solani. Ruíz-Cendoya M; Mariné M; Guarro J J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651 [TBL] [Abstract][Full Text] [Related]
6. Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine. Ruíz-Cendoya M; Pastor FJ; Capilla J; Guarro J Int J Antimicrob Agents; 2011 Jan; 37(1):58-61. PubMed ID: 20947310 [TBL] [Abstract][Full Text] [Related]
7. The High Diversity and Variable Susceptibility of Clinically Relevant Acremonium-Like Species in China. Yao L; Wang H; Wan Z; Li R; Yu J Mycopathologia; 2019 Dec; 184(6):759-773. PubMed ID: 31655952 [TBL] [Abstract][Full Text] [Related]
9. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii. Lackner M; Fernández-Silva F; Guarro J; Lass-Flörl C J Antimicrob Chemother; 2014 Nov; 69(11):3027-32. PubMed ID: 24986494 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection. Ruíz-Cendoya M; Madrid H; Pastor J; Guarro J Int J Antimicrob Agents; 2010 Feb; 35(2):152-5. PubMed ID: 20005680 [TBL] [Abstract][Full Text] [Related]
12. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections. Groll AH; Walsh TJ Mycoses; 2006; 49 Suppl 1():7-16. PubMed ID: 16961576 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies. Fernández-Silva F; Capilla J; Mayayo E; Sutton D; Guarro J Antimicrob Agents Chemother; 2014; 58(2):1259-60. PubMed ID: 24247142 [No Abstract] [Full Text] [Related]
14. Combined therapy against murine-disseminated infection by Fusarium verticillioides. Ruíz-Cendoya M; Pastor J; Guarro J Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029 [TBL] [Abstract][Full Text] [Related]
15. Purpureocillium roseum sp. nov. A new ocular pathogen for humans and mice resistant to antifungals. Calvillo-Medina RP; Ponce-Angulo DG; Raymundo T; Müller-Morales CA; Escudero-Leyva E; Campos Guillén J; Bautista-de Lucio VM Mycoses; 2021 Feb; 64(2):162-173. PubMed ID: 33064905 [TBL] [Abstract][Full Text] [Related]
16. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Perkhofer S; Lass-Flörl C Expert Opin Investig Drugs; 2009 Sep; 18(9):1393-404. PubMed ID: 19656074 [TBL] [Abstract][Full Text] [Related]